Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2381144Generated: November 1, 2026

4-{1-[3-(Trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl}phenol → 6-[4-(4-{2-[(3S)-4-acetyl-3-methylpiperazin-1-yl]ethoxy}phenyl)piperidin-1-yl]-3-(trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazine

https://huagongshe.com/reaction/2381144

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-{1-[3-(Trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl}phenolHCID 68500430—
Reactant(S)-2-(4-acetyl-3-methylpiperazin-1-yl)ethanolHCID 68504459—
Product6-[4-(4-{2-[(3S)-4-acetyl-3-methylpiperazin-1-yl]ethoxy}phenyl)piperidin-1-yl]-3-(trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazineHCID 4689256841%

Reaction Steps

Obtained in 41% yield by an analogous method to Example 51, starting from 4-{1-[3-(trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl}phenol and (S)-2-(4-acetyl-3-methylpiperazin-1-yl)ethanol (obtained by an analogous method to the R enantiomer as described in Example 51, preparation of starting materials).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08258140B2
Source datasetuspto-grants-2012_09
ORD IDord-333b07a67f264d2cb4fad15660f5b9c6
Source noteuspto-grants-2012_09